Mid
H
HUMAI Stock Diagnostic Report
Morgan Stanley upgrades Humana stock rating on 2028 margin confidence
Morgan Stanley has upgraded Humana's stock rating based on confidence in margin improvement by 2028.
View Source Article ↗AI CATALYST SCORE80 / 100Score computed by Sentinel V12
REFERENCE PRICE$362.1600036621094Reference entry price at analysis time
01
FUNDAMENTALS
Financial & Fundamental Analysis
Based on the outlook for margin recovery in 2028, the improvement in Medicare Advantage margins and expectations for a turnaround serve as factors supporting the lower end of the financial valuation.
02
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
Morgan Stanley's upgrade of its investment rating and confidence in margins for 2028 serve as momentum to alleviate uncertainties in the Medicare Advantage sector.